-
Primary prophylaxis needed for candidiasis?
No!
-
Tx for oropharyngeal
- fluconazole 100 mg po qday x 7-14 days
- or
- clotrimazole troches 10 mg fid
- nystatin susp 4-6 ml qid
- alternative: itrconazole soln 200 mg qday
-
Tx for esophageal candidiasis
- fluconazole 100 mg (up to 400mg) po or IV qday
- itraconazole soln 200 mg qday
-
Tx for vulvovaginal candidiasis
- fluconazole 150 mg po for 1 dose
- topical azole for 3-7 days
- alternative: itraconazole soln 200 mg bid x 1 day or 200 mg qday x 3 days
- complicated or recurrent: fluconazole 150 mg po q 72 hrs for 2-3 doses, topical antifungal agents greater than 7 days
-
What CD4 count is candidiasis more prevelant?
<200
-
When is PCP more prevelant?
- when patients are unaware they have HIV
- those who are not in care
- CD4 count <100
-
Risk factors for PCP
- CD4 count <200
- prior PCP
- CD4% <14%
- oral thrush
- recurrent bacterial pneumonia
- unintentional weight loss
- high viral load
-
When and what to prophylaxis for PCP and when to stop?
- CD4 count <200 or hx of oropharyngeal
- d/c with CD4 >200 for >3 months, but reinitiate when CD4 <200
- bactrim (ss or ds) 1 po qday
- dapsone 100 mg po qday (test for G6PD first)
-
Tx for PCP
- TMP-SMX 15-20 mg/kg/day in divided doses q 6-8 hours
- or
- Bactrim DS 2 ts po tid
- alternative (moderate to severe): pentamidine 4 mg/kg IV qday or
- primaquine 15-30 mg (base) po qd + clinda 600-900 mg IV q6-8h
- atovaquone 750 mg po bid
- could add steroids for moderate to severe disease (room air <70 mmHg or A-a gradient >35 mmHg) but need to taper x 21 days
-
Secondary prophylaxis of PCP
- bactrim ds or ss 1 po qday
- patient can d/c if cd4 count >200
- but if patient gets PCP while cd4 >200 will be on bactrim for life
-
TB epidemiology
- injection drug users
- occurs at any CD4 count
- patients with TB have higher HIV viral loads and faster progression of HIV
- all HIV patients should be screened for latent TB at HIV diagnosis
- annual testing is also recommended
-
Tx of LTBI
- INH 300 mg PPO qd or 900 mg BIW for 9 months
- plus
- pyridoxine 50 mg po qd to reduce risk of peripheral neuropathy
- alternative: rifampin 300 mg qd x 4 months
-
Tx of TB disease
- Initial phase (2 months)- RIPE
- Continuation phase (4 months)- INH + RIF or (RFB)
- if positive cultures after initial 2 months, contine RIPE for 3 more months (total of 9 months)
-
Rifamycins interact with what classes of ART?
- PI
- CCR5
- Integrase inhibitors
-
MAC epidemiology and risk factors
- usually occurs in CD4 count <50
- risk factors: viral load >100,000 copies, previous opportunistic infection, previous colonization with MAC
-
CD4 counts for prophylaxis for MAC
- CD4 <50
- d/c in patient on ART with increase in CD4 count >100 for greater than 3 months
- restart prophylxis if CD4 <50 again
-
Primary prophylaxis for MAC
- azithromycin 1200 mg po qweek
- clarithromycin 500 mg po bid
- azithromycin po TIW
- alternative: RFB 300 mg po qd
-
Tx for MAC
- initial tx at least 12 months
- clarithromycin 500 mg po bid + ethambutol 15 mg/kg po qd
- alternative to clarithromycin: azithromycin 500-600 mg po qday
- consider adding RFB as 3rd drug- especially if CD4 <50
- consider adding fluoroquinolones, amikacin, streptomycin
-
Epidemiology of cryptococcus
- CD4 <50
- if relapse occurs, almost always fatal
-
Tx for cryptococcus
- induction: greater than 2 weeks. amphotericin 0.7 mg/kg IV QD + flucytosine 25 mg/kg po QID
- Consolidation: 8 weeks. Fluconazole 400 mg po qd
- chronic maintenance: fluconazole 200 mg po qd
- consolidation therapy should not be started until at least 2 weeks of significant clinical improvment, and negative CSF culture on lumbar puncture
-
Epidemiology of histoplasmosis
- grows in bird and bat droppings
- seen in CD4 <150
-
primary prophylaxis for histoplasmosis
- itraconazole- can reduce frequency of disease but no survival benefit
- itraconazole 200 mg po qd for patients CD4 <200
- can d/c when CD4 >150 x 6 months
-
Tx for histoplasmosis
- induction: (2 weeks or until clinically improved) amp B
- maintenance: itraconazole 200 mg po tid x 3 days then bid
- total duration at least 12 months
- if meningitis: induction 4-6 weeks
-
Epidemiology of Toxoplasmosis
acquired from tissue cysts in undercooked meat or ingestion of sporulated oocysts (from cat feces) in soil, water, or food
-
Primary prophylaxis of Toxoplasmosis
- CD4 <100
- bactrim ds 1 po qd
- d/c if on ART, CD4>200 for >3 months
- restart if CD4 <200
-
Tx for toxoplasmosis
- pryrimethamine + sulfadiazine + leucovorin
- duration at least 6 weeks
-
CMV: preventing disease
- maintain CD4 >100
- primary prophylaxis with valganciclovir not recommended
- regular eye exams
- vigilance for increase in floaters
-
CMV treatment for retinitis
- IV ganciclovir followed by oral valganciclovir
- IV foscarnet
- IV cidofovir
- ganciclovir intraocular implant
- valganciclovir
- tx for colitis, esophagitis: IV ganciclovir or foscarnet; oral valganciclovir for 21-28 days, maintenance not necessary
|
|